BROSSARD, QUEBEC--(Marketwired - Aug. 28, 2015) - DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence and advanced knowledge-extraction techniques, announces that the board of directors of the Corporation has approved an amendment to the Corporation's stock option plan in order to increase the maximum number of common shares that may be issued pursuant thereto from 12,000,000 to 20,000,000 to provide long-term incentives aimed at achieving the Corporation's growth plans.
This amendment is subject to TSX Venture acceptance and disinterested shareholder approval at the Annual General Meeting of shareholders scheduled for September 24, 2015.
About DIAGNOS
Founded in 1998, DIAGNOS is a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including healthcare and natural resources.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.